FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025157210> ?p ?o ?g. }

• W3025157210 endingPage "104421" @default.
• W3025157210 startingPage "104421" @default.
• W3025157210 abstract "The emergence of herpes simplex virus (HSV) resistance to aciclovir (ACV) has increasingly been reported among hematopoietic stem cell transplant (HSCT) recipients and often associated with extended ACV prophylaxis. Between June 2011 and June 2019, medical records of 532 HSCT recipients with suspected HSV infection were retrospectively analyzed. HSV-1 and HSV-2 positive samples were identified in 47 and 16 patients respectively. Analysis of HSV resistance to antivirals was performed at the Public Health England reference laboratory in London using phenotypic and/or genotypic resistance assays. The prevalence of ACV-resistant HSV accounted for 17% (8/48) of infected HSV-1 cases. All 8 patients received T-cell depleted allogeneic HSCT for hematological malignancies. Half of these patients were male with a median age was 57.5 years (range; 26–63). Chronic Graft versus Host disease (cGVHD) affected 7 patients before HSV-1 diagnosis. HSV-1 infection developed while receiving either intravenous ACV (n = 2) or oral ACV (n = 6 patients) prophylaxis at a median of 373 [range,18–2183] days post-HSCT. ACV resistance was clinically suspected at a median of 25 [range,16–109] days after initial HSV diagnosis and subsequently laboratory confirmed at a median of 25 (range,10–59) days. All patients presented with hemorrhagic oral mucositis refractory to treatment dose ACV. Foscarnet (FOS) treatment was initiated in all 8 patients (pending laboratory confirmation of ACV resistance) with some effect but associated with significant toxicity burden. Four patients presented again with recurrent HSV infection or no resolution. Three with recurrent HSV died from other causes while suffering from persistent oral HSV lesions. A prolonged immunosuppressed state following T-deplete HSCTs alongside extended use of ACV, early onset systemic HSV infection, presence of cGVHD, and treatment toxicities pose a significant challenge to the management of ACV resistant HSV infections and alternative effective antiviral options remains an unmet need in this clinical setting." @default.
• W3025157210 created "2020-05-21" @default.
• W3025157210 creator A5007230365 @default.
• W3025157210 creator A5013682606 @default.
• W3025157210 creator A5024771458 @default.
• W3025157210 creator A5026190469 @default.
• W3025157210 creator A5030102793 @default.
• W3025157210 creator A5032585809 @default.
• W3025157210 creator A5037549778 @default.
• W3025157210 creator A5039384107 @default.
• W3025157210 creator A5077595049 @default.
• W3025157210 creator A5081252933 @default.
• W3025157210 date "2020-07-01" @default.
• W3025157210 modified "2023-09-24" @default.
• W3025157210 title "Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients" @default.
• W3025157210 cites W1965845098 @default.
• W3025157210 cites W1999480417 @default.
• W3025157210 cites W2009538412 @default.
• W3025157210 cites W2011806268 @default.
• W3025157210 cites W2012284605 @default.
• W3025157210 cites W2014013945 @default.
• W3025157210 cites W2033899181 @default.
• W3025157210 cites W2039773104 @default.
• W3025157210 cites W2043841254 @default.
• W3025157210 cites W2050228012 @default.
• W3025157210 cites W2051865862 @default.
• W3025157210 cites W2076800252 @default.
• W3025157210 cites W2088194309 @default.
• W3025157210 cites W2090765690 @default.
• W3025157210 cites W2101492913 @default.
• W3025157210 cites W2113417823 @default.
• W3025157210 cites W2145781384 @default.
• W3025157210 cites W2148365504 @default.
• W3025157210 cites W2155142648 @default.
• W3025157210 cites W2156244991 @default.
• W3025157210 cites W2161596769 @default.
• W3025157210 cites W2166775938 @default.
• W3025157210 cites W2337976486 @default.
• W3025157210 cites W2443997199 @default.
• W3025157210 cites W2479037074 @default.
• W3025157210 cites W2764022981 @default.
• W3025157210 doi "https://doi.org/10.1016/j.jcv.2020.104421" @default.
• W3025157210 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32417677" @default.
• W3025157210 hasPublicationYear "2020" @default.
• W3025157210 type Work @default.
• W3025157210 sameAs 3025157210 @default.
• W3025157210 citedByCount "13" @default.
• W3025157210 countsByYear W30251572102020 @default.
• W3025157210 countsByYear W30251572102021 @default.
• W3025157210 countsByYear W30251572102022 @default.
• W3025157210 countsByYear W30251572102023 @default.
• W3025157210 crossrefType "journal-article" @default.
• W3025157210 hasAuthorship W3025157210A5007230365 @default.
• W3025157210 hasAuthorship W3025157210A5013682606 @default.
• W3025157210 hasAuthorship W3025157210A5024771458 @default.
• W3025157210 hasAuthorship W3025157210A5026190469 @default.
• W3025157210 hasAuthorship W3025157210A5030102793 @default.
• W3025157210 hasAuthorship W3025157210A5032585809 @default.
• W3025157210 hasAuthorship W3025157210A5037549778 @default.
• W3025157210 hasAuthorship W3025157210A5039384107 @default.
• W3025157210 hasAuthorship W3025157210A5077595049 @default.
• W3025157210 hasAuthorship W3025157210A5081252933 @default.
• W3025157210 hasConcept C126322002 @default.
• W3025157210 hasConcept C141071460 @default.
• W3025157210 hasConcept C203014093 @default.
• W3025157210 hasConcept C2522874641 @default.
• W3025157210 hasConcept C2776409557 @default.
• W3025157210 hasConcept C2776694085 @default.
• W3025157210 hasConcept C2776724271 @default.
• W3025157210 hasConcept C2777408962 @default.
• W3025157210 hasConcept C2778496288 @default.
• W3025157210 hasConcept C2779450786 @default.
• W3025157210 hasConcept C2780452071 @default.
• W3025157210 hasConcept C2780727368 @default.
• W3025157210 hasConcept C2781196997 @default.
• W3025157210 hasConcept C2911091166 @default.
• W3025157210 hasConcept C71924100 @default.
• W3025157210 hasConcept C90924648 @default.
• W3025157210 hasConceptScore W3025157210C126322002 @default.
• W3025157210 hasConceptScore W3025157210C141071460 @default.
• W3025157210 hasConceptScore W3025157210C203014093 @default.
• W3025157210 hasConceptScore W3025157210C2522874641 @default.
• W3025157210 hasConceptScore W3025157210C2776409557 @default.
• W3025157210 hasConceptScore W3025157210C2776694085 @default.
• W3025157210 hasConceptScore W3025157210C2776724271 @default.
• W3025157210 hasConceptScore W3025157210C2777408962 @default.
• W3025157210 hasConceptScore W3025157210C2778496288 @default.
• W3025157210 hasConceptScore W3025157210C2779450786 @default.
• W3025157210 hasConceptScore W3025157210C2780452071 @default.
• W3025157210 hasConceptScore W3025157210C2780727368 @default.
• W3025157210 hasConceptScore W3025157210C2781196997 @default.
• W3025157210 hasConceptScore W3025157210C2911091166 @default.
• W3025157210 hasConceptScore W3025157210C71924100 @default.
• W3025157210 hasConceptScore W3025157210C90924648 @default.
• W3025157210 hasLocation W30251572101 @default.
• W3025157210 hasOpenAccess W3025157210 @default.
• W3025157210 hasPrimaryLocation W30251572101 @default.
• W3025157210 hasRelatedWork W2003370236 @default.

• next